New pill ZX-8177 tested in patients with advanced cancers
Disease control
Recruiting now
This early-stage study tests a new pill called ZX-8177 in about 80 Chinese adults with advanced solid tumors that have not responded to standard treatments. The main goals are to check the drug's safety, find the best dose, and see if it can shrink tumors. Participants will take …
Phase: PHASE1 • Sponsor: Nanjing Zenshine Pharmaceuticals • Aim: Disease control
Last updated May 14, 2026 12:04 UTC